Stage III Grade 3 Follicular Lymphoma Completed Phase Trials for Palifermin (DB00039)

IndicationStatusPhase
DBCOND0028630 (Stage III Grade 3 Follicular Lymphoma)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01233921Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic CancerSupportive Care